[go: up one dir, main page]

ID23653A - Pencegahan kanker payudara dengan modulator reseptor estrogen selektif - Google Patents

Pencegahan kanker payudara dengan modulator reseptor estrogen selektif

Info

Publication number
ID23653A
ID23653A IDW991189A ID991189A ID23653A ID 23653 A ID23653 A ID 23653A ID W991189 A IDW991189 A ID W991189A ID 991189 A ID991189 A ID 991189A ID 23653 A ID23653 A ID 23653A
Authority
ID
Indonesia
Prior art keywords
estrogent
selective
breast cancer
receptor modulators
cancer prevention
Prior art date
Application number
IDW991189A
Other languages
English (en)
Indonesian (id)
Inventor
Andrew Lawrence Glasebrook
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID23653A publication Critical patent/ID23653A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IDW991189A 1997-04-09 1998-04-07 Pencegahan kanker payudara dengan modulator reseptor estrogen selektif ID23653A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4311897P 1997-04-09 1997-04-09

Publications (1)

Publication Number Publication Date
ID23653A true ID23653A (id) 2000-05-11

Family

ID=21925594

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991189A ID23653A (id) 1997-04-09 1998-04-07 Pencegahan kanker payudara dengan modulator reseptor estrogen selektif

Country Status (15)

Country Link
EP (1) EP0975628A4 (no)
JP (1) JP2001518897A (no)
KR (1) KR20010006215A (no)
CN (1) CN1259945A (no)
AU (1) AU6957398A (no)
CA (1) CA2286207A1 (no)
EA (1) EA199900910A1 (no)
HU (1) HUP0001845A2 (no)
ID (1) ID23653A (no)
IL (1) IL132279A0 (no)
NO (1) NO994902L (no)
PL (1) PL336206A1 (no)
TR (1) TR199903244T2 (no)
WO (1) WO1998045286A1 (no)
ZA (1) ZA982818B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610706B1 (en) 1999-07-29 2003-08-26 Eli Lilly And Company Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
US6653479B1 (en) 1999-07-29 2003-11-25 Eli Lilly And Company Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride
EA022760B1 (ru) 2007-10-16 2016-02-29 Репрос Терапьютикс Инк. Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
AU2013225869B2 (en) 2012-02-29 2017-06-08 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
MA38325B1 (fr) 2013-02-19 2019-03-29 Novartis Ag Dérivés de benzothiophène et compositions correspondantes en tant qu'agents de dégradation sélectifs des récepteurs des œstrogènes
GB201311888D0 (en) * 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
JP7048505B2 (ja) 2015-11-10 2022-04-05 パラクリン セラピューティクス エービー Pdgf-cc阻害剤および抗エストロゲン剤によるer陰性乳癌の処置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3989569B2 (ja) * 1995-02-28 2007-10-10 イーライ リリー アンド カンパニー ベンゾチオフェン化合物、中間体、組成物および方法
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
US5731342A (en) * 1996-02-22 1998-03-24 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods

Also Published As

Publication number Publication date
ZA982818B (en) 1999-10-04
EP0975628A4 (en) 2001-03-21
EP0975628A1 (en) 2000-02-02
WO1998045286A1 (en) 1998-10-15
TR199903244T2 (xx) 2000-05-22
CN1259945A (zh) 2000-07-12
HUP0001845A2 (hu) 2001-06-28
NO994902L (no) 1999-12-07
NO994902D0 (no) 1999-10-08
KR20010006215A (ko) 2001-01-26
AU6957398A (en) 1998-10-30
CA2286207A1 (en) 1998-10-15
EA199900910A1 (ru) 2000-04-24
IL132279A0 (en) 2001-03-19
JP2001518897A (ja) 2001-10-16
PL336206A1 (en) 2000-06-05

Similar Documents

Publication Publication Date Title
EP0971588A4 (en) NEW CANNABINOID RECEPTOR MODULATORS
EG25606A (en) Glucocorticoid receptor modulators
ZA991301B (en) Glutamate receptor modulators.
NO20005508L (no) Adenosin-A3-reseptormodulatorer
NO20002527L (no) Enkeltkjede bifunksjonelle glykoproteinhormoner
AU4557099A (en) Novel therapeutic agents that modulate estrogen receptors
ID27986A (id) Pengobatan terhadap gangguan sistem syaraf pusat dengan modulator reseptor estrogen selektif
DE69840285D1 (de) Mehrkanaliger akustisch-optischer Modulator
EP1189919A4 (en) TESTING MODULATORS OF APOPTOSIS
PL361053A1 (en) Estrogen receptor modulators
DE69841441D1 (de) FM-Modulator
ID23653A (id) Pencegahan kanker payudara dengan modulator reseptor estrogen selektif
NO992699D0 (no) Fyllingssystem
GB9803062D0 (en) Estrogen receptor ligands
FI973602A0 (fi) Modulaer omformare
GB9711992D0 (en) Estrogen receptor ligands
GB9717346D0 (en) Estrogen receptor ligands
FI970695A0 (fi) Datalink
GB9722884D0 (en) Estrogen receptor
IL156851A0 (en) Adenosine a3 receptor modulators
IL156852A0 (en) Adenosine a3 receptor modulators
PL317909A1 (en) Optoelectronic modulator
HUP0002758A3 (en) Non-steroidal ligands for the estrogen receptor
FIU970321U0 (fi) Kaivumaiden levityslaite
BR9701559A (pt) Dispositivo para comunicação através de cores-padr o